Authors: Goh, BC Ratain, MJ Bertucci, D Smith, R Mani, S Vogelzang, NJ Schilsky, RL Hutchison, M Smith, M Averbuch, S Douglass, E

Citation: Bc. Goh et al., Phase I study of ZD9331 on short daily intravenous bolus infusion for 5 days every 3 weeks with fixed dosing recommendations, J CL ONCOL, 19(5), 2001, pp. 1476-1484

Authors: Goh, BC Fleming, GF Janisch, L Vogelzang, NJ Stadler, WM Ratain, MJ

Citation: Bc. Goh et al., Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations, CANC CHEMOT, 45(6), 2000, pp. 489-494

Authors: Goh, BC Lehnert, M Lim, HL Ng, AWK Chan, CC Kong, HL Lee, SC Wee, J Chua, ET Wong, JEL

Citation: Bc. Goh et al., Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer, ACTA ONCOL, 39(2), 2000, pp. 225-229

Authors: Vokes, EE Goh, BC Bertucci, D Vogelzang, NJ Mani, S Ratain, MJ

Citation: Ee. Vokes et al., A Phase I study of raltitrexed and paclitaxel given every 3 weeks to patients with solid tumors, CANCER, 86(3), 1999, pp. 528-532